| MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity H Su, JR Yang, T Xu, J Huang, L Xu, Y Yuan, SM Zhuang Cancer research 69 (3), 1135-1142, 2009 | 740 | 2009 |
| CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients L Chen, THM Chan, YF Yuan, L Hu, J Huang, S Ma, J Wang, SS Dong, ... The Journal of clinical investigation 120 (4), 1178-1191, 2010 | 175 | 2010 |
| Long-term outcomes and prognostic factors of elderly patients with hepatocellular carcinoma undergoing hepatectomy J Huang, BK Li, GH Chen, JQ Li, YQ Zhang, GH Li, YF Yuan Journal of gastrointestinal surgery 13 (9), 1627-1635, 2009 | 136 | 2009 |
| Interleukin 23 promotes hepatocellular carcinoma metastasis via NF-kappa B induced matrix metalloproteinase 9 expression J Li, G Lau, L Chen, YF Yuan, J Huang, JM Luk, D Xie, XY Guan Public Library of Science 7 (9), e46264, 2012 | 108 | 2012 |
| Mutations of p53 and K-ras correlate TF expression in human colorectal carcinomas: TF downregulation as a marker of poor prognosis B Rao, Y Gao, J Huang, X Gao, X Fu, M Huang, J Yao, J Wang, W Li, ... International journal of colorectal disease 26, 593-601, 2011 | 88 | 2011 |
| Clostridium difficile toxins induce VEGF-A and vascular permeability to promote disease pathogenesis J Huang, CP Kelly, K Bakirtzi, JAV Gálvez, D Lyras, SJ Mileto, ... Nature microbiology 2019 (4), 269–279, 2018 | 67 | 2018 |
| Clinical significance of CHD1L in hepatocellular carcinoma and therapeutic potentials of virus-mediated CHD1L depletion L Chen, YF Yuan, Y Li, THM Chan, BJ Zheng, J Huang, XY Guan Gut 60 (4), 534-543, 2011 | 56 | 2011 |
| Aberrant expression of long noncoding RNA SNHG15 correlates with liver metastasis and poor survival in colorectal cancer L Huang, H Lin, L Kang, P Huang, J Huang, J Cai, Z Xian, P Zhu, ... Journal of cellular physiology 234 (5), 7032-7039, 2019 | 52 | 2019 |
| Clinical outcomes of active specific immunotherapy in advanced colorectal cancer and suspected minimal residual colorectal cancer: a meta-analysis and system review B Rao, M Han, L Wang, X Gao, J Huang, M Huang, H Liu, J Wang Journal of Translational Medicine 9, 1-11, 2011 | 45 | 2011 |
| Screening of pH-responsive and long circulating polysaccharide-drug conjugate nanocarriers for anti-tumor applications YKJW Xinyu Zhang, Dandan Li, Jun Huang, Kunyong Ou, Binyuan Yan, Fu Shi ... J. Mater. Chem. B, 2018 | 44* | 2018 |
| Elevated tumor-to-liver uptake ratio (TLR) from 18F–FDG-PET/CT predicts poor prognosis in stage IIA colorectal cancer following curative resection J Huang, L Huang, J Zhou, Y Duan, Z Zhang, X Wang, P Huang, S Tan, ... European journal of nuclear medicine and molecular imaging 44, 1958-1968, 2017 | 42 | 2017 |
| The Monoclonal Antitoxin Antibodies (Actoxumab–Bezlotoxumab) Treatment Facilitates Normalization of the Gut Microbiota of Mice with Clostridium difficile Infection M Džunková, G D'Auria, H Xu, J Huang, Y Duan, A Moya, CP Kelly, ... Frontiers in cellular and infection microbiology 6, 119, 2016 | 39 | 2016 |
| Partial hepatectomy for liver metastases from nasopharyngeal carcinoma: a comparative study and review of the literature J Huang, Q Li, Y Zheng, J Shen, B Li, R Zou, J Wang, Y Yuan BMC cancer 14, 1-10, 2014 | 32 | 2014 |
| Synthesis, characterization, and formulation of poly-puerarin as a biodegradable and biosafe drug delivery platform for anti-cancer therapy T Yi, J Huang, X Chen, H Xiong, Y Kang, J Wu Biomaterials science 7 (5), 2152-2164, 2019 | 23 | 2019 |
| Associations between the cyclooxygenase‐2 expression in circulating tumor cells and the clinicopathological features of patients with colorectal cancer J Cai, L Huang, J Huang, L Kang, H Lin, P Huang, P Zhu, J Wang, J Dong, ... Journal of Cellular Biochemistry 120 (4), 4935-4941, 2019 | 20 | 2019 |
| Clostridioides difficile toxin A remodels membranes and mediates DNA entry into cells to activate toll-like receptor 9 signaling X Chen, X Yang, J de Anda, J Huang, D Li, H Xu, KS Shields, ... Gastroenterology 159 (6), 2181-2192. e1, 2020 | 16 | 2020 |
| The tumor immune microenvironment transcriptomic subtypes of colorectal cancer for prognosis and development of precise immunotherapy YQ Tang, TF Chen, Y Zhang, XC Zhao, YZ Zhang, GQ Wang, ML Huang, ... Gastroenterology Report 8 (5), 381-389, 2020 | 15 | 2020 |
| Single-agent neoadjuvant immunotherapy with a PD-1 antibody in locally advanced mismatch repair-deficient or microsatellite instability-high colorectal cancer F Pei, J Wu, Y Zhao, W He, Q Yao, M Huang, J Huang Clinical Colorectal Cancer 22 (1), 85-91, 2023 | 11 | 2023 |
| Molecular typing and clinical characteristics of synchronous multiple primary colorectal cancer Y Zhao, J Wu, F Pei, Y Zhang, S Bai, L Shi, X Zhang, J Ma, X Zhao, T Ma, ... JAMA Network Open 5 (11), e2243457-e2243457, 2022 | 11 | 2022 |
| Downregulation of phosphorylated MKK4 is associated with a poor prognosis in colorectal cancer patients PN Wang, J Huang, YH Duan, JM Zhou, PZ Huang, XJ Fan, Y Huang, ... Oncotarget 8 (21), 34352, 2017 | 10 | 2017 |
